Establishment, Verification and Clinical Application of Chinese Version of Surgical Risk Assessment System

Postoperative Complications Clinical Trial

— CSRAS  

Official title:

Establishment, Verification and Clinical Application of Chinese Version of Surgical Risk Assessment System

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05754268
• Other study ID #: CSRAS
• Status: Recruiting
• Start date: January 1, 2022
• Est. completion date: December 31, 2024

Study information

• Verified date: March 2023
• Source: The Affiliated Hospital of Qingdao University
• Contact: Ju Yiheng, Doctor
• Phone: 17562468826
• Email: juyiheng0815[@]163.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The goal of this observational study is to establish and verify the Chinese version of surgical risk assessment system and explore its clinical application. The main questions it aims to answer are: The process of establishing a Chinese version of surgical risk assessment system; What is the accuracy of the system; How can the system be used in clinic; How does this system compare with other systems (such as NSQIP). Participants will comprehensively collect the general information, examination and pathological information of the patients, using machine learning and artificial intelligence methods for data processing. Finally, the Chinese version of the surgical risk assessment system will be established. After the system is established, investigators will evaluate the accuracy of the system and compare it with other related systems.

Description:

The research process is as follows:

1. Determine the collection index and the complications to be evaluated, and retrospectively collect the preoperative clinical data (including preoperative medical records, examination and examination results) of patients with postoperative complications of gastric and colorectal cancer in our hospital in the past ten years. Preliminary construction of surgical risk assessment system (gastrointestinal surgery)

2. Retrospective or prospective collection of gastric cancer and colorectal surgery cases (not included in the system)

3. The occurrence of postoperative complications was observed until 1 month after discharge. Compare the evaluation results of the system with the actual situation and feedback to further improve the system.

4. The same batch of patient data can be input into NSQIP to re-evaluate and predict the occurrence of patient complications, and then compare the results of the two systems.

5. The incidence of postoperative complications (number of cases and accuracy) of the two groups were counted respectively, and the accuracy and practicability of the evaluation of the two systems were compared to further improve the system.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 10000
• Est. completion date: December 31, 2024
• Est. primary completion date: August 31, 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Preoperative colonoscopy and biopsy confirmed gastric and colorectal cancer.

• Laparotomy or laparoscopic radical resection of gastric or colorectal cancer.

• No postoperative complications such as pneumonia, venous thrombosis, cardiovascular and cerebrovascular accidents occurred before operation.

• There was no serious organ dysfunction before operation.

• Complete auxiliary examination and the availability of examination and examination data were carried out before operation.

Exclusion Criteria:

• Complicated with malignant tumors of other organs.

• Unresectable tumors.

• Distant metastasis.

• Severe organ system dysfunction before operation.

• Patients with non-operative treatment.

Related Conditions & MeSH terms

• Artificial Intelligence
• Machine Learning
• Postoperative Complications
• Risk Assessment
• Risk Factors

Intervention

Procedure:
• Chinese version of the surgical risk assessment system
There is no need to interfere with the patient. Investigators can observe the outcome after using the system for evaluation.

Locations

Country	Name	City	State
China	Yiheng Ju	Qingdao	Shan Dong

Sponsors (1)

Lead Sponsor	Collaborator
luyun

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The occurrence of complications	The following complications occurred or did not occur in the patient: death, cardio-cerebrovascular accident, pneumonia, lower extremity deep venous thrombosis, anastomotic fistula, incision infection, intrabody periorgan infection, systemic septicemia, urinary system infection, renal insufficiency / failure, unplanned reoperation, intestinal obstruction.	Within one month after the operation